Mayflower Financial Advisors, LLC Revelation Biosciences, Inc. Transaction History

Mayflower Financial Advisors, LLC

  • $1.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023
BUY
$0.18 - $431.55 $3,856 - $9.25 Million
21,425 New
21,425 $0
Q3 2022

Oct 19, 2022
BUY
$0.09 - $1438.5 $1,928 - $30.8 Million
21,425 New
21,425 $6,000
Q1 2022

Apr 21, 2022
BUY
$971.04 - $11077.5 $20.8 Million - $237 Million
21,425 New
21,425 $24,000

Others Institutions Holding REVB

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About REVELATION BIOSCIENCES, INC.

REVB Quotes by TradingView
  • Ticker REVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,525,800
  • Market Cap $20M
  • Description
  • Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal conge...
More about REVB
Track This Portfolio

Track Mayflower Financial Advisors, LLC Portfolio

Follow Mayflower Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email